Institutional investors purchased a net $750.1 thousand shares of GHDX during the quarter ended March 2016 and now own 93.11% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LOOMIS, SAYLES & CO. LP Bought 631.4 Thousand shares of Genomic Health Inc
ACADIAN ASSET MANAGEMENT LLC Bought 466.8 Thousand shares of Genomic Health Inc
BAKER BROS. ADVISORS LP Bought 273.1 Thousand shares of Genomic Health Inc